Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine.
第一作者:
Sangeetha,Venugopal
第一单位:
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
作者:
医学主题词
抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿扎胞苷(Azacitidine);细胞遗传学分析(Cytogenetic Analysis);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);预后(Prognosis);磺胺类(Sulfonamides)
DOI
10.1080/10428194.2021.1973675
PMID
34474640
发布时间
2024-09-23
基金项目
P30 CA016672/CA/NCI NIH HHS/United States
R01 CA231364/CA/NCI NIH HHS/United States
R01 CA235622/CA/NCI NIH HHS/United States
- 浏览0
Leukemia & lymphoma
3501-3505页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



